Portage Biotech Announces $6M Registered Direct Offering
Portfolio Pulse from Benzinga Newsdesk
Portage Biotech has announced a $6M registered direct offering.
September 29, 2023 | 12:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Portage Biotech's $6M registered direct offering could potentially dilute existing shareholders' equity.
Registered direct offerings increase the number of shares in circulation, which can dilute the value of existing shares. This could potentially lead to a decrease in PRTG's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100